[EN] FUSED BICYCLIC HETEROCYCLES AS THEREAPEUTIC AGENTS<br/>[FR] HÉTÉROCYCLES BICYCLIQUES FUSIONNÉS EN TANT QU'AGENTS THÉRAPEUTIQUES
申请人:UNIV NEW YORK
公开号:WO2020073031A1
公开(公告)日:2020-04-09
This disclosure relates to compounds, pharmaceutical compositions comprising them, and methods of using the compounds and compositions for treating diseases related to nicotinamide phosphoribosyltransferase (NAM FT) expression. More particularly, this disclosure relates to fused bicyclic heterocyclic compounds and pharmaceutical compositions thereof, methods of inhibiting NAM FT with these compounds, and methods of treating diseases related to NAMPT expression.
这份披露涉及化合物、包含它们的药物组合物,以及使用这些化合物和组合物治疗与烟酰胺磷酸核糖转移酶(NAM FT)表达相关的疾病的方法。更具体地,这份披露涉及融合的双环杂环化合物及其药物组合物,使用这些化合物抑制NAM FT的方法,以及治疗与NAMPT表达相关疾病的方法。